Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dimebon”

28 trials

Showing 20 of 28 results

Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Large-scale testing (Phase 3)Ended earlyNCT01085266
What this trial is testing

An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease

Who this might be right for
Huntington Disease
Medivation, Inc. 362
Early research (Phase 1)Study completedNCT00831532
What this trial is testing

Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function

Who this might be right for
Hepatic Failure
Pfizer 23
Large-scale testing (Phase 3)Looking for participantsNCT07251023
What this trial is testing

Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia

Who this might be right for
Alzheimer Type Dementia
Bigespas LTD 450
Early research (Phase 1)Study completedNCT00827034
What this trial is testing

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 14
Early research (Phase 1)Study completedNCT00988624
What this trial is testing

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

Who this might be right for
Alzheimer's DiseaseHuntington Disease
Pfizer 20
Early research (Phase 1)Study completedNCT00825084
What this trial is testing

Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 45
Large-scale testing (Phase 3)Ended earlyNCT01066546
What this trial is testing

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 5
Early research (Phase 1)Study completedNCT00990613
What this trial is testing

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 19
Large-scale testing (Phase 3)Ended earlyNCT00954590
What this trial is testing

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer
Medivation, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00829374
What this trial is testing

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 1,003
Early research (Phase 1)Study completedNCT00788047
What this trial is testing

Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan

Who this might be right for
Huntington DiseaseAlzheimer Disease
Pfizer 14
Large-scale testing (Phase 3)Ended earlyNCT00939783
What this trial is testing

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 649
Early research (Phase 1)Study completedNCT00975481
What this trial is testing

Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 36
Early research (Phase 1)Study completedNCT00907322
What this trial is testing

Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults

Who this might be right for
Healthy Volunteers
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT00838110
What this trial is testing

Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 742
Large-scale testing (Phase 3)Ended earlyNCT01152216
What this trial is testing

An Extension of the CONCERT Protocol (DIM18)

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 672
Testing effectiveness (Phase 2)Study completedNCT00387270
What this trial is testing

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

Who this might be right for
Huntington's Disease
Medivation, Inc. 9
Large-scale testing (Phase 3)Study completedNCT00675623
What this trial is testing

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 598
Testing effectiveness (Phase 2)Study completedNCT00497159
What this trial is testing

The Novel Drug Dimebon in Patients With Huntington's Disease

Who this might be right for
Huntington's Disease
Medivation, Inc. 91
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation